Literature DB >> 24491658

Anesthesia for craniofacial surgery in infancy.

Paul A Stricker1, John E Fiadjoe2.   

Abstract

Anesthetic management of infants undergoing craniofacial surgery can be challenging. Primary concerns for the anesthesiologist include blood loss and its management. The evolution of procedures to treat craniosynostosis has resulted in improvements in perioperative morbidity, including decreased blood loss and transfusion, shorter operations, and shorter hospital stays. An understanding of the procedures performed to treat craniosynostosis is necessary to provide optimal anesthetic management. Descriptions of current surgical techniques and approaches to anesthetic care are presented in this review.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Craniofacial surgery; Craniosynostosis; Endoscopic; Pediatrics; Transfusion

Mesh:

Year:  2013        PMID: 24491658     DOI: 10.1016/j.anclin.2013.10.007

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  4 in total

1.  Use of blood-sparing surgical techniques and transfusion algorithms: association with decreased blood administration in children undergoing primary open craniosynostosis repair.

Authors:  Thanh T Nguyen; Sarah Hill; Thomas M Austin; Gina M Whitney; John C Wellons; Humphrey V Lam
Journal:  J Neurosurg Pediatr       Date:  2015-07-31       Impact factor: 2.375

Review 2.  Endoscopic craniosynostosis repair.

Authors:  Mark R Proctor
Journal:  Transl Pediatr       Date:  2014-07

3.  Cranial growth in isolated sagittal craniosynostosis compared with normal growth in the first 6 months of age.

Authors:  Ezgi Mercan; Richard A Hopper; A Murat Maga
Journal:  J Anat       Date:  2019-11-06       Impact factor: 2.610

Review 4.  Endoscopic treatment of sagittal suture synostosis - a critical analysis of current management strategies.

Authors:  Julia Heider; Malte Ottenhausen; Verena Fassl; Laura Ellermann; Gabriele Reichelt; Phillipe Pape; Christoph Blecher; Christian Hoffmann; Florian Ringel; Bilal Al-Nawas
Journal:  Neurosurg Rev       Date:  2022-04-06       Impact factor: 2.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.